Alzeca Biosciences, Llc;Board of Regents of the University of Houston System;Texas Children's Hospital;Board Of Regents Of the University Of Texas System
发明人:
申请号：
EP18167725.3
公开号：
EP3366313A1
申请日:
2012.04.06
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Lipid-based nanoparticle compositions are provided. The compositions generally comprise lipid-hydrophilic polymer-amyloid binding ligand conjugates, and may be liposomal compositions. The compositions, including the liposomal compositions, may be useful for imaging and/or the treatment of amyloid-β plaque deposits characteristic of Alzheimer's Disease.
